Home » Newsletters » BioWorld Science

BioWorld Science

April 7, 2008

View Archived Issues

Effects of INO-8875 on atrioventricular nodal conduction shown in rats

Enhanced lipid effects seen with ezetimibe/simvastatin plus niacin in hyperlipidemia

BTG presents an update on the company's clinical development programs

Satoris enters collaboration with Mayo Clinic to validate early Alzheimer's test

Dr. Reddy's signs definitive agreement to acquire portion of Dowpharma Small

EMEA approves Forsteo for treatment of glucocorticoid-induced osteoporosis

FDA approves Rotarix, a pediatric rotavirus vaccine

Recent patents impart novel metabolic drugs

AZD-1480, a novel JAK2 inhibitor profiled at AstraZeneca

Efficacy of radiotherapy enhanced by SPI-1620

GenVec receives USD 600,000 grant from NIH for malaria vaccine program

Recent patents disclose novel therapeutic agents for inflammatory disorders

EntreMed initiates phase I clinical trial of MKC-1 in metastatic solid tumors

Recent patents describe new treatment options for respiratory disorders

Alfacell reports evaluable events from phase IIIb clinical trial of Onconase

Radius completes enrollment in phase II clinical trial of BA-058 for osteoporosis

PharmAthene acquires Avecia's biodefense vaccines business

ActivBiotics sells intellectual property assets for USD 3.5 million

CG Therapeutics and the University of Washington to develop human monoclonal antibodies

Vical receives USD 2.0 million NIH grant for immunotherapeutic herpes DNA vaccine

EMEA grants orphan drug designation to Tengion for Neo-Bladder Augment for spina bifida

Preclinical profile of Merck's novel HCV protease inhibitor reported at the ACS meeting

EpiCept reports positive clinical data from phase I EPC-2407 trial